UVI 3003 is a highly selective antagonist of retinoid X receptor (RXR) , and inhibits xenopus and human RXRα in Cos7 cells, with IC 50 s of 0.22 and 0.24 μM, respectively.
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Autophagy | Products > Research Areas > Others | Products > Signaling Pathways > RAR/RXR | Products > Signaling Pathways > Autophagy
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.